<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T06:53:03Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4192028" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:4192028</identifier>
        <datestamp>2014-10-21</datestamp>
        <setSpec>npgopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Eur J Clin Nutr</journal-id>
              <journal-id journal-id-type="iso-abbrev">Eur J Clin Nutr</journal-id>
              <journal-title-group>
                <journal-title>European Journal of Clinical Nutrition</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0954-3007</issn>
              <issn pub-type="epub">1476-5640</issn>
              <publisher>
                <publisher-name>Nature Publishing Group</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC4192028</article-id>
              <article-id pub-id-type="pmcid">PMC4192028</article-id>
              <article-id pub-id-type="pmc-uid">4192028</article-id>
              <article-id pub-id-type="pmid">24961547</article-id>
              <article-id pub-id-type="pii">ejcn2014114</article-id>
              <article-id pub-id-type="doi">10.1038/ejcn.2014.114</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Vitamin D and <sc>L</sc>-cysteine levels correlate positively with GSH and negatively with insulin resistance levels in the blood of type 2 diabetic patients</article-title>
                <alt-title alt-title-type="running">Vitamin D and LC supplements—an adjuvant therapy for IR in T2D</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jain</surname>
                    <given-names>S K</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                  <xref ref-type="corresp" rid="caf1">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Micinski</surname>
                    <given-names>D</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Huning</surname>
                    <given-names>L</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kahlon</surname>
                    <given-names>G</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bass</surname>
                    <given-names>P F</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Levine</surname>
                    <given-names>S N</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                </contrib>
                <aff id="aff1"><label>1</label><institution>Department of Pediatrics, Louisiana State University Health Sciences Center</institution>, Shreveport, LA, <country>USA</country></aff>
                <aff id="aff2"><label>2</label>Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA</aff>
              </contrib-group>
              <author-notes>
                <corresp id="caf1"><label>*</label><institution>Department of Pediatrics, Louisiana State University Health Sciences Center</institution>, 1501 Kings Highway, Shreveport, LA 71130, <country>USA</country>. E-mail: <email>sjain@lsuhsc.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="ppub">
                <month>10</month>
                <year>2014</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>25</day>
                <month>06</month>
                <year>2014</year>
              </pub-date>
              <volume>68</volume>
              <issue>10</issue>
              <fpage>1148</fpage>
              <lpage>1153</lpage>
              <history>
                <date date-type="received">
                  <day>02</day>
                  <month>01</month>
                  <year>2014</year>
                </date>
                <date date-type="rev-recd">
                  <day>30</day>
                  <month>04</month>
                  <year>2014</year>
                </date>
                <date date-type="accepted">
                  <day>07</day>
                  <month>05</month>
                  <year>2014</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2014 Macmillan Publishers Limited</copyright-statement>
                <copyright-year>2014</copyright-year>
                <copyright-holder>Macmillan Publishers Limited</copyright-holder>
                <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
                  <!--author-paid-->
                  <license-p>This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link></license-p>
                </license>
              </permissions>
              <abstract>
                <sec>
                  <title>Background/Objectives:</title>
                  <p>Vitamin D, <sc>L</sc>-cysteine (LC) and glutathione (GSH) levels are lower in the blood of diabetic patients. This study examined the hypothesis that the levels of vitamin D and LC correlate with those of GSH in the blood of type 2 diabetic patients (T2D), and that vitamin D and LC upregulate glutamate–cysteine ligase (GCLC), which catalyzes GSH biosynthesis, in cultured monocytes.</p>
                </sec>
                <sec>
                  <title>Subjects/Methods:</title>
                  <p>Fasting blood was obtained after written informed consent from T2D (<italic>n</italic>=79) and healthy controls (<italic>n</italic>=22). U937 monocytes were pretreated with 1,25 (OH)<sub>2</sub> vitamin D (0–25 n<sc>M</sc>) or LC (0–500 μ<sc>M</sc>) for 24 h and then exposed to control or high glucose (25 m<sc>M</sc>) for 4 h.</p>
                </sec>
                <sec>
                  <title>Results:</title>
                  <p>Plasma levels of vitamin D, LC, GSH and GCLC protein were significantly lower in T2D versus those in age-matched healthy controls. Multiple linear regression analyses and adjustment for body weight showed a significant positive correlation between plasma levels of vitamin D (<italic>r</italic>=0.26, <italic>P</italic>=0.05) and LC (<italic>r</italic>=0.81, <italic>P</italic>=0.001) and that of GSH, and between LC and vitamin D (<italic>r</italic>=0.27, <italic>P</italic>=0.045) levels. Plasma levels of GSH (<italic>r</italic>=−0.34, <italic>P</italic>=0.01) and LC (<italic>r</italic>=−0.33, <italic>r</italic>=0.01) showed a negative correlation with triglyceride levels. Vitamin D correlated inversely with HbA<sub>1C</sub> (−0.30, <italic>P</italic>=0.01) and homeostatic model assessment insulin resistance (<italic>r</italic>=−0.31, <italic>P</italic>=0.03), which showed a significant positive correlation with triglycerides (<italic>r</italic>=0.44, <italic>P</italic>=0.001) in T2D. Cell culture studies demonstrate that supplementation with vitamin D and LC significantly increased GCLC expression and GSH formation in control and high-glucose-treated monocytes.</p>
                </sec>
                <sec>
                  <title>Conclusions:</title>
                  <p>This study suggests a positive relationship between the concentrations of the micronutrients vitamin D and LC and that of GSH. Some of the beneficial effects of vitamin D and LC supplementation may be mediated by an increase in the levels of GSH and a decrease in triglyceride levels in T2D patients.</p>
                </sec>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro">
              <title>Introduction</title>
              <p>Reduced glutathione (GSH) is the most prevalent non-protein thiol found in mammalian cells.<sup><xref ref-type="bibr" rid="bib1">1</xref>,<xref ref-type="bibr" rid="bib2">2</xref></sup> GSH has a major role in the detoxification of a variety of electrophilic compounds, including peroxides and oxygen radicals catalyzed by glutathione S-transferases, and in the glutathione peroxidase system.<sup><xref ref-type="bibr" rid="bib1">1</xref>,<xref ref-type="bibr" rid="bib2">2</xref></sup> In addition, the redox status of GSH has a significant role in signal transduction, gene expression, apoptosis, protein glutathionylation and the maintenance of appropriate protein structure and function.<sup><xref ref-type="bibr" rid="bib1">1</xref>,<xref ref-type="bibr" rid="bib2">2</xref></sup> Alteration in GSH levels is associated with a wide variety of pathologies, such as cancer, HIV, lung disease, Parkinson's disease and diabetes. These studies have led to the free radical theory of human disease and to the advancement of nutritional therapies aimed at improving GSH status under various pathological conditions.<sup><xref ref-type="bibr" rid="bib3">3</xref>,<xref ref-type="bibr" rid="bib4">4</xref></sup></p>
              <p>GSH is made up of the amino acids glutamine, cysteine and glycine. These amino acids are known to have a direct or indirect role in the maintenance of glucose homeostasis by influencing gene expression and insulin secretion in pancreatic β-cells.<sup><xref ref-type="bibr" rid="bib3">3</xref>,<xref ref-type="bibr" rid="bib4">4</xref></sup> High concentrations of glutamate exist in skeletal muscle, coupled with a strong correlation between glutamate and GSH levels, which makes it a major player in the maintenance of glucose metabolism.<sup><xref ref-type="bibr" rid="bib5">5</xref></sup> Glutamate levels decrease under catabolic conditions in skeletal muscle.<sup><xref ref-type="bibr" rid="bib5">5</xref></sup> Elevated glucagon levels increase the uptake of glutamine and glycine by the liver, causing the lower blood levels of glutamate, glycine and <sc>L</sc>-cysteine (LC) seen in diabetes.<sup><xref ref-type="bibr" rid="bib3">3</xref>,<xref ref-type="bibr" rid="bib4">4</xref>,<xref ref-type="bibr" rid="bib6">6</xref>, <xref ref-type="bibr" rid="bib7">7</xref>, <xref ref-type="bibr" rid="bib8">8</xref>, <xref ref-type="bibr" rid="bib9">9</xref></sup> These amino acids are vital for the maintenance of circulating and tissue levels of GSH, which protects against the increased oxidative insults common to diabetes.</p>
              <p>Vitamin D blood levels are lower in diabetes and its deficiency is associated with a higher incidence of complications in diabetic patients.<sup><xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref></sup> The biochemical pathways influenced by vitamin D in lowering hyperglycemia and its associated complications in diabetes remain to be determined. GSH is formed from LC and <sc>L</sc>-glutamate by the enzymatic action of glutamate–cysteine ligase (GCLC), and subsequent glycine incorporation catalyzed by glutathione synthase.<sup><xref ref-type="bibr" rid="bib1">1</xref>,<xref ref-type="bibr" rid="bib2">2</xref></sup> Whether there is any relationship between circulating levels of vitamin D and LC and those of GSH in diabetic patients is not known. This study reports a positive relationship between plasma levels of LC and vitamin D with those of GSH, which in turn shows a negative relationship with the elevated triglycerides and insulin resistance seen in type 2 diabetic (T2D) patients. In addition, cell culture studies demonstrate that both vitamin D and LC supplementation increases GCLC expression and GSH formation in high-glucose-treated U937 monocytes. Thus, when sufficient nutritional amounts of vitamin D and LC are present in the body, levels of GSH increase, thereby decreasing insulin resistance levels in T2D patients.</p>
            </sec>
            <sec sec-type="materials|methods">
              <title>Materials and methods</title>
              <sec>
                <title>Patient enrollment</title>
                <p>Informed written consent was obtained from all patients according to the protocol approved by the Louisiana State University Health Sciences Center (LSUHSC) Institutional Review Board. All patients included in this study were healthy adults with type 2 diabetes. All patients who gave written informed consent were invited to return to have blood drawn after fasting overnight. Volunteers for healthy controls were enrolled from a group including siblings of patients or workers at LSUHSC.</p>
              </sec>
              <sec>
                <title>Inclusion/exclusion criteria</title>
                <p>Adult T2D patients attending the diabetic clinic at LSUHSC hospital were included in the study. Patients were excluded if they had any history of cardiovascular disease, sickle cell disease, treatment with insulin or metabolic disorders, including uncontrolled hypertension, abnormal parathyroid, hypothyroidism or hyperthyroidism. Patients were excluded if they showed signs of significant hepatic dysfunction, defined as any underlying chronic liver disease or liver function tests &gt;1.5 times the upper limit of normal, or renal dysfunction, defined as a serum creatinine value &gt;1.5 mg/dl. Women with a positive pregnancy test or those nursing infants were also excluded. Subjects who were taking any supplemental vitamins or herbal products were not included in this study.</p>
              </sec>
              <sec>
                <title>Blood collection</title>
                <p>Blood was drawn from healthy adults and T2D patients after an overnight fast (8 h). Following blood collection, serum tubes for chemistry profile, EDTA tubes for HbA<sub>1C</sub> and complete blood counts were promptly delivered to the LSUHSC clinical laboratories. Additional tubes of EDTA blood were brought to the research laboratory. Clear plasma was separated via centrifugation at 3000 r.p.m. (1500 × <italic>g</italic>) for 15 min. All plasma samples were stored at −80 °C for analyses of the biochemical parameters.</p>
              </sec>
              <sec>
                <title>Human pro-monocytic cell line</title>
                <p>The U937 monocyte cell line was obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). These cells were maintained at 37 °C in RPMI 1640 medium containing 7 m<sc>M</sc> glucose, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 12 m<sc>M</sc> sodium carbonate, 12 m<sc>M</sc> HEPES and 2 m<sc>M</sc> glutamine in a humidified atmosphere containing 5% (v/v) CO<sub>2</sub>. For treatments, cells were washed once in plain RPMI 1640 before being suspended in fresh medium (complete) containing serum and other supplements.<sup><xref ref-type="bibr" rid="bib13">13</xref></sup></p>
              </sec>
              <sec>
                <title>Treatment with high glucose, LC and vitamin D</title>
                <p>Cells (15 ml; 10<sup>6</sup>/ml) were taken in a T-25 cm<sup>2</sup> cell culture flask and pretreated with LC and 1,25(OH)<sub>2</sub> vitamin D for 24 h, followed by high glucose (25 m<sc>M</sc>) exposure for the next 4 h. 1,25(OH)<sub>2</sub> vitamin D is an active form of vitamin D. In this study control cells were exposed to media with a concentration of 7 m<sc>M</sc> glucose. In the body, glucose is continuously degraded and re-formed to maintain a 5 m<sc>M</sc> blood glucose level. However, in cell culture studies, we observed that incubating cells with media with a concentration of 5 m<sc>M</sc> glucose for 24 h caused a decrease in glucose concentrations to levels &lt;2 m<sc>M</sc>. In cell culture studies, glucose gets metabolized but not replaced. For this reason, and drawing on our previous experience, we found that using a concentration of 7 m<sc>M</sc> glucose does not lead to a glucose deficiency after 24- h incubation. In high glucose studies, cells were exposed to a high glucose concentration of 25 m<sc>M</sc>. In some experiments, cells were instead exposed to 18 m<sc>M</sc> mannitol (control) as the media contain 7 m<sc>M</sc> glucose. After treatment, cells were lysed in radioimmunoprecipitation assay buffer for use in western blotting studies.</p>
              </sec>
              <sec>
                <title>GSH, LC, GCLC, vitamin D, HOMA insulin resistance and cell viability assays</title>
                <p>GSH and LC levels were determined using high-performance liquid chromatography.<sup><xref ref-type="bibr" rid="bib14">14</xref></sup> The level of GCLC total protein in the plasma was determined using an ELISA kit (catalog #MBS 704124, MyBiosource, San Diego, CA, USA). The level of GCLC protein was expressed as total protein. Insulin levels in the plasma were determined using the sandwich ELISA method with commercially available kits from Fisher Thermo Scientific Co (Rockford, IL, USA). Plasma levels of 1,25(OH)<sub>2</sub> vitamin D were determined using an ELISA kit (catalog #VID31-K01, Eagle Biosciences, Nashua, NH, USA). Insulin resistance was calculated from blood glucose and insulin levels using the homeostatic model assessment insulin resistance (HOMA IR) formula.<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> HOMA IR was calculated using the following formula: (plasma insulin (μU/ml) × glucose (mg%))/405. All appropriate controls and standards as specified by the manufacturer's kit were used each time. In cell culture studies, the whole cell suspension was processed for each GSH assay, and GSH concentration is expressed per volume of cell suspension. Cell viability was determined using the Alamar Blue reduction bioassay (Alamar Biosciences, Sacramento, CA, USA). This method is based on Alamar Blue dye reduction by live cells.</p>
              </sec>
              <sec>
                <title>Western blotting analyses of cell lysates</title>
                <p>At the end of treatment, cells were lysed in radioimmunoprecipitation assay buffer (50 m<sc>M</sc> Tris pH 8, 150 m<sc>M</sc> NaCl, 1% NP-40, 0.5% deoxycholic acid and 0.1% SDS) supplemented with protease and phosphatase inhibitors (1 m<sc>M</sc> PMSF, 5 μg/ml leupeptin, 2 μg/ml aprotinin, 1 m<sc>M</sc> EDTA, 10 m<sc>M</sc> NaF and 1 m<sc>M</sc> NaVO<sub>4</sub>). Lysates were subjected to mild sonication, centrifuged at 15 000 r.p.m. (4 °C, 30 min) and the supernatants collected. Total protein concentrations were determined using the BCA assay (Pierce/Thermo Scientific, Rockford, IL, USA). Equal amounts of protein (20 μg) from each group were loaded onto 10% SDS-polyacrylamide gel after boiling for 5 min with β-mercaptoethanol as a reducing agent. The separated proteins were transferred to a nitrocellulose membrane, blocked with 1% bovine serum albumin in T-PBS (0.25% Tween-20 in phosphate-buffered saline (PBS)), and incubated overnight at 4 °C with the respective primary antibodies using 1:500 dilutions. The next day, membranes were washed with T-PBS (8 min, four cycles) and incubated with secondary antibodies conjugated with horseradish peroxidase in 5% non-fat milk for 30 min at room temperature. The membranes were again washed with T-PBS (8 min, four cycles), treated with chemiluminescence reagents for 2 min and exposed to X-ray films developed through autoradiography. β-Actin antibody was used to assess the loading equality. The antibody for GCLC (73 kDa) was purchased from Abcam (Cambridge, MA, USA). The intensity of each band reported here was measured using ImageJ Software from NIH (Bethesda, MD, USA).</p>
                <p>All chemicals were purchased from Sigma Chemical Co (St Louis, MO, USA) unless otherwise mentioned. Data were analyzed statistically using analysis of variance to compare differences between diabetic patients and age-matched healthy subjects. Multiple linear regression analyses were used to determine whether dependent variable can be predicted from a linear combination of independent variables. Body weight was always used as additional independent variable to determine regression and <italic>P-</italic>value. Y-axis parameter as dependent, x-axis and body weight were used as independent variables using Sigma Stat software (San Jose, CA, USA). For cell culture studies, Student's <italic>t</italic>-test was used to compare the differences between treatments using Sigma plot statistical software (SPSS, San Jose, CA, USA). A <italic>P-</italic>value &lt;0.05 was considered significant.</p>
              </sec>
            </sec>
            <sec sec-type="results">
              <title>Results</title>
              <sec>
                <title>Vitamin D, LC and GSH levels in diabetic patients and control subjects</title>
                <p><xref rid="tbl1" ref-type="table">Table 1</xref> shows the similar distribution of age, F/M ratio, and race in both groups. Body weight and BMI, as well as the blood parameters HOMA IR, triglycerides, and fasting glucose levels, were higher in diabetic patients compared with those of control subjects. Plasma levels of LC, GSH and GCLC are lower in the plasma of T2D patients compared with those of age-matched controls (<xref rid="tbl1" ref-type="table">Table 1</xref>). Similarly, plasma levels of vitamin D were lower in T2D compared with those of age-matched control subjects. The vitamin D level was lower whether vitamin D was expressed per n<sc>M</sc> (volume) of plasma or per cholesterol+TG levels. This difference was examined because vitamin D is a lipid-soluble vitamin similar to vitamin E and it may be more appropriate to express its concentrations after normalization with lipid as has been argued for vitamin E.<sup><xref ref-type="bibr" rid="bib16">16</xref></sup></p>
              </sec>
              <sec>
                <title>Relationship between vitamin D, LC, GSH, HbA1c and HOMA IR levels in diabetic patients</title>
                <p><xref ref-type="fig" rid="fig1">Figure 1</xref> shows that blood GSH levels were significantly positively dependent on vitamin D (<xref ref-type="fig" rid="fig1">Figure 1b</xref>) and LC (<xref ref-type="fig" rid="fig1">Figure 1d</xref>) levels in diabetic patients. This suggests that circulating vitamin D can help boost blood GSH status. Similarly, <xref ref-type="fig" rid="fig1">Figure 1c</xref> illustrates that a significant correlation exists between blood levels of LC and those of vitamin D.</p>
                <p><xref ref-type="fig" rid="fig2">Figure 2</xref> shows that there was a statistically significant inverse regression dependence of triglyceride levels with blood levels of GSH (<xref ref-type="fig" rid="fig2">Figure 2f</xref>) and LC (<xref ref-type="fig" rid="fig2">Figure 2c</xref>), but that the inverse relationship between GSH and cholesterol was not statistically significant (<italic>r</italic>=−0.18, <italic>P</italic>=0.12, data not given). This suggests that blood GSH status has a positive effect on lowering lipid levels. There was a significant inverse regression relation of HOMA IR (<xref ref-type="fig" rid="fig2">Figure 2e</xref>) with that of vitamin D, while triglyceride levels were positively correlated with those of HOMA IR (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). The relationship between cholesterol levels and those of HOMA IR (not shown here) was also significant (<italic>r</italic>=0.31, <italic>P</italic>=0.01). <xref ref-type="fig" rid="fig2">Figure 2</xref> also shows a significant inverse relationship between HbA1c and vitamin D levels. The regression analyses given here were determined while controlling for body weights using multiple linear regression analyses.</p>
              </sec>
              <sec>
                <title>Effect of vitamin D or LC supplementation on GCLC and GSH in cultured monocytes</title>
                <p>GSH is formed from LC by the enzymatic action of GCLC.<sup><xref ref-type="bibr" rid="bib17">17</xref></sup> To determine whether lower LC and vitamin D levels have any role in lowering GSH levels in diabetic patients, we examined the hypothesis that LC and vitamin D upregulate the GCLC enzyme, which regulates GSH biosynthesis. <xref ref-type="fig" rid="fig3">Figure 3</xref> shows that both LC and vitamin D increase GCLC expression in monocytes treated with control and high glucose. Similarly, there was a modest but significantly higher GSH level in cells supplemented with LC and vitamin D compared with that of respective controls. The effect of vitamin D on GCLC has also been reported in a previous study.<sup><xref ref-type="bibr" rid="bib18">18</xref></sup> Mannitol treatment had no effect on GCLC or GSH formation (data not given here). There was no change in cell viability in any of the treatments. This suggests that lower levels of LC and vitamin D may have a role in lowering GSH levels in the blood of T2D patients.</p>
              </sec>
            </sec>
            <sec sec-type="discussion">
              <title>Discussion</title>
              <p>This study found lower plasma levels of LC, GSH and GCLC in diabetic patients compared with those in age-matched healthy controls. GCLC catalyzes the first step of the biosynthesis of GSH from LC and glutamate. This suggests that the observed decrease in GSH may be mediated by decreased levels of GCLC in diabetic patients. The lower levels of LC and vitamin D observed in T2D is consistent with those reported in previous studies.<sup><xref ref-type="bibr" rid="bib6">6</xref>,<xref ref-type="bibr" rid="bib7">7</xref>,<xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref></sup> Multiple linear regression analyses after adjustment for body weight showed a significant correlation between plasma levels of LC and vitamin D and those of GSH levels in diabetic patients. The data also showed a significant inverse correlation between GSH and LC levels and those of triglycerides, which in turn showed a significant positive correlation with HOMA IR levels in T2D patients.</p>
              <p>The positive correlation between LC and vitamin D status with GSH levels in diabetic patients is a new finding. To rule out the role of variables such as obesity and parathryroid hormone in diabetic patients, we investigated the direct effect of supplementation of LC and vitamin D on GSH levels in monocytes using cell culture studies. The cell culture studies also demonstrate that the LC and 1,25(OH)<sub>2</sub> vitamin D caused increased GCLC expression and GSH formation in monocytes. Taken together, the correlation seen in diabetic patients become validated because similar results were obtained with cell culture studies. This suggests that vitamin D and LC status directly and positively influence the GSH levels in the absence of other variables.</p>
              <p>Diabetes is associated with elevated blood levels of biomarkers of oxidative stress and vascular inflammation.<sup><xref ref-type="bibr" rid="bib19">19</xref>, <xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib21">21</xref></sup> Cell culture studies suggest that pro-inflammatory cytokines (such as TNF-α or IL-1β) may cause the release of glutamate and thereby inhibition of LC uptake and decreased GSH synthesis; elevated oxidative stress in various tissues from uncontrolled hyperglycemia may also cause increased utilization of GSH or LC, thereby resulting in the lower GSH levels seen in diabetes.<sup><xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib5">5</xref>,<xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib23">23</xref></sup> Increased glutamine and glycine uptake by the liver can cause lower blood levels of glutamate, glycine and LC as well as serine—an amino acid important for glycine and LC synthesis, which is also often found to be lower in diabetes.<sup><xref ref-type="bibr" rid="bib3">3</xref>,<xref ref-type="bibr" rid="bib4">4</xref></sup> Lower blood levels of vitamin D or LC may be associated with the life style, obesity, vitamin D binding protein and vascular inflammation commonly associated with diabetes.<sup><xref ref-type="bibr" rid="bib2">2</xref>,<xref ref-type="bibr" rid="bib3">3</xref>,<xref ref-type="bibr" rid="bib21">21</xref></sup> This study reports a positive relationship between plasma levels of LC and vitamin D and those of GSH, which in turn shows a negative relationship with the triglycerides and insulin resistance seen in T2D. Thus, sufficient nutritional amounts of vitamin D and LC independently can increase levels of GSH and thereby decrease insulin resistance levels in T2D patients.</p>
              <p>Amino acids such as arginine, <sc>L</sc>-alanine, glutamine and LC are known to stimulate the gene expression of enzymes, such as glutamate dehydrogenase and aminotransferases, as well as insulin secretion in pancreatic β-cells.<sup><xref ref-type="bibr" rid="bib4">4</xref></sup> Supplementation with cysteine-rich proteins (whey protein and α-lactoalbumin), LC, <italic>N</italic>-acetylcysteine or the cysteinate form of different compounds is beneficial in lowering oxidative stress, insulin resistance and glycemia in diabetic animal and human studies.<sup><xref ref-type="bibr" rid="bib24">24</xref>, <xref ref-type="bibr" rid="bib25">25</xref>, <xref ref-type="bibr" rid="bib26">26</xref>, <xref ref-type="bibr" rid="bib27">27</xref>, <xref ref-type="bibr" rid="bib28">28</xref>, <xref ref-type="bibr" rid="bib29">29</xref>, <xref ref-type="bibr" rid="bib30">30</xref>, <xref ref-type="bibr" rid="bib31">31</xref>, <xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref>, <xref ref-type="bibr" rid="bib35">35</xref>, <xref ref-type="bibr" rid="bib36">36</xref>, <xref ref-type="bibr" rid="bib37">37</xref></sup> Skeletal muscle has an important role in glucose metabolism and contains high concentrations of glutamate and GSH.<sup><xref ref-type="bibr" rid="bib5">5</xref></sup> Whether supplementation with glutamate, a precursor of GSH, can improve GSH status and glucose metabolism in skeletal muscle needs investigation. Other micronutrients, such as chlorogenic acid, can also increase GSH levels and prevent liver injury.<sup><xref ref-type="bibr" rid="bib23">23</xref></sup> Intravenous GSH infusion significantly increased the intraerythrocytic GSH/GSSH ratio and total glucose uptake in diabetic patients.<sup><xref ref-type="bibr" rid="bib38">38</xref></sup> Administration of GSH inhibited the insulin resistance in skeletal muscle caused by lipid infusion in mice<sup><xref ref-type="bibr" rid="bib39">39</xref></sup> and in Wistar rats.<sup><xref ref-type="bibr" rid="bib40">40</xref></sup> A recent study reported a positive effect on insulin sensitivity and body composition in older HIV-infected patients as the result of increasing GSH with cysteine supplementation.<sup><xref ref-type="bibr" rid="bib41">41</xref></sup> Reduced levels of GSH can increase oxidative stress, resulting in the oxidative modification of lipoproteins that can lead to the accumulation of the cholesterol and triglycerides known to induce insulin resistance.<sup><xref ref-type="bibr" rid="bib1">1</xref>,<xref ref-type="bibr" rid="bib2">2</xref></sup> Taken together, the results from these studies in the literature and the findings, that a significant negative correlation exists between GSH status and triglyceride levels in T2D patients, indicate that an increase in GSH levels can lower insulin resistance and have a positive effect on glucose metabolism.</p>
              <p>The beneficial effects of vitamin D may occur via upregulation of expression of insulin receptors and the glucose transporter, regulation of the calcium pool, modulation of immune and inflammatory cytokine expression (and thereby improvement of insulin action in peripheral tissues) and/or by direct action on pancreatic β-cell function.<sup><xref ref-type="bibr" rid="bib10">10</xref>,<xref ref-type="bibr" rid="bib11">11</xref>,<xref ref-type="bibr" rid="bib42">42</xref>,<xref ref-type="bibr" rid="bib43">43</xref></sup> This study suggests that some effects of vitamin D are mediated by improvement of the GSH status. Vitamin D is known for its beneficial effects on calcium and other skeletal biomarkers. It is possible that some of the nonskeletal beneficial effects of vitamin D are mediated through its antioxidant action.<sup><xref ref-type="bibr" rid="bib44">44</xref></sup> Vitamin D is a lipid-soluble vitamin similar to vitamin E. Studies in the literature suggest that the ratio of serum vitamin E to total lipids is the more reliable biochemical index of vitamin E status.<sup><xref ref-type="bibr" rid="bib16">16</xref></sup> Whether the status of vitamin D is better reflected when expressed per lipid needs further investigation.</p>
              <p>In conclusion, this study reports a significant positive relationship between blood levels of LC and vitamin D and those of GSH, and a negative relationship with insulin resistance in T2D patients. New knowledge concerning the nutritional regulation of GSH metabolism may help in the development of effective strategies to improve the health of T2D patients. Future clinical trials are needed to evaluate the potential benefits of supplementation with vitamin D and LC in boosting the status of GSH and lowering hyperglycemia in T2D. If such a trial were to lead to tangible clinical results, it would demonstrate the potential of vitamin D and LC supplementation as an adjuvant therapy in preventing the insulin resistance associated with obesity and diabetes.</p>
            </sec>
          </body>
          <back>
            <ack>
              <p>The authors are supported by grants from NIDDK and the ODS (RO1 DK072433) and the Malcolm Feist Endowed Chair in Diabetes. The authors thank Ms Morgan for excellent editing.</p>
            </ack>
            <notes>
              <p>The authors declare no conflict of interest.</p>
            </notes>
            <ref-list>
              <ref id="bib1">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Franco</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Schoneveld</surname>
                      <given-names>OJ</given-names>
                    </name>
                    <name>
                      <surname>Pappa</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Panayiotidis</surname>
                      <given-names>MI</given-names>
                    </name>
                  </person-group>
                  <article-title>The central role of glutathione in the pathophysiology of human diseases</article-title>
                  <source>Arch Physiol Biochem</source>
                  <year>2007</year>
                  <volume>113</volume>
                  <fpage>234</fpage>
                  <lpage>258</lpage>
                  <pub-id pub-id-type="pmid">18158646</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib2">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Fang</surname>
                      <given-names>YZ</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Lupton</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>ND</given-names>
                    </name>
                  </person-group>
                  <article-title>Glutathione metabolism and its implications for health</article-title>
                  <source>J Nutr</source>
                  <year>2004</year>
                  <volume>134</volume>
                  <fpage>489</fpage>
                  <lpage>492</lpage>
                  <pub-id pub-id-type="pmid">14988435</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib3">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Newsholme</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Rebelato</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Abdulkader</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Krause</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Carpinelli</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Curi</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Reactive oxygen and nitrogen species generation, antioxidant defenses, and β-cell function: a critical role for amino acids</article-title>
                  <source>J Endocrinol</source>
                  <year>2012</year>
                  <volume>214</volume>
                  <fpage>11</fpage>
                  <lpage>20</lpage>
                  <pub-id pub-id-type="pmid">22547566</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib4">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Newsholme</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Krause</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Nutritional regulation of insulin secretion: implications for diabetes</article-title>
                  <source>Clin Biochem Rev</source>
                  <year>2012</year>
                  <volume>33</volume>
                  <fpage>35</fpage>
                  <lpage>47</lpage>
                  <pub-id pub-id-type="pmid">22896743</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib5">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rutten</surname>
                      <given-names>EP</given-names>
                    </name>
                    <name>
                      <surname>Engelen</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Schols</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Deutz</surname>
                      <given-names>NE</given-names>
                    </name>
                  </person-group>
                  <article-title>Skeletal muscle glutamate metabolism in health and disease: state of the art</article-title>
                  <source>Curr Opin Clin Nutr Metab Care</source>
                  <year>2005</year>
                  <volume>8</volume>
                  <fpage>41</fpage>
                  <lpage>51</lpage>
                  <pub-id pub-id-type="pmid">15585999</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib6">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sekhar</surname>
                      <given-names>RV</given-names>
                    </name>
                    <name>
                      <surname>McKay</surname>
                      <given-names>SV</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>SG</given-names>
                    </name>
                  </person-group>
                  <article-title>Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine</article-title>
                  <source>Diabetes Care</source>
                  <year>2011</year>
                  <volume>34</volume>
                  <fpage>162</fpage>
                  <lpage>167</lpage>
                  <pub-id pub-id-type="pmid">20929994</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib7">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Darmaun</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Sweeten</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hartman</surname>
                      <given-names>BK</given-names>
                    </name>
                    <name>
                      <surname>Welch</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Mauras</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Poorly controlled type 1 diabetes is associated with altered glutathione homeostasis in adolescents: apparent resistance to N-acetylcysteine supplementation</article-title>
                  <source>Pediatr Diabetes</source>
                  <year>2008</year>
                  <volume>9</volume>
                  <fpage>577</fpage>
                  <lpage>582</lpage>
                  <pub-id pub-id-type="pmid">19067892</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib8">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>McVie</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients</article-title>
                  <source>Metabolism</source>
                  <year>1994</year>
                  <volume>43</volume>
                  <fpage>306</fpage>
                  <lpage>309</lpage>
                  <pub-id pub-id-type="pmid">8139478</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib9">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Darmaun</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Sweeten</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sager</surname>
                      <given-names>BK</given-names>
                    </name>
                    <name>
                      <surname>Welch</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Mauras</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes</article-title>
                  <source>Diabetes</source>
                  <year>2005</year>
                  <volume>54</volume>
                  <fpage>190</fpage>
                  <lpage>196</lpage>
                  <pub-id pub-id-type="pmid">15616028</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib10">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mitri</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Muraru</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Pittas</surname>
                      <given-names>AG</given-names>
                    </name>
                  </person-group>
                  <article-title>Vitamin D and type 2 diabetes: a systematic review</article-title>
                  <source>Eur J Clin Nutr</source>
                  <year>2011</year>
                  <volume>65</volume>
                  <fpage>1005</fpage>
                  <lpage>1015</lpage>
                  <pub-id pub-id-type="pmid">21731035</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib11">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rosen</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Adams</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Bikle</surname>
                      <given-names>DD</given-names>
                    </name>
                    <name>
                      <surname>Black</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Demay</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Manson</surname>
                      <given-names>JE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The nonskeletal effects of vitamin D: an endocrine society scientific statement</article-title>
                  <source>Endocr Rev</source>
                  <year>2012</year>
                  <volume>33</volume>
                  <fpage>456</fpage>
                  <lpage>492</lpage>
                  <pub-id pub-id-type="pmid">22596255</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib12">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grant</surname>
                      <given-names>WB</given-names>
                    </name>
                  </person-group>
                  <article-title>An estimate of the global reduction in mortality rates through doubling vitamin D levels</article-title>
                  <source>Eur J Clin Nutr</source>
                  <year>2011</year>
                  <volume>65</volume>
                  <fpage>1016</fpage>
                  <lpage>1026</lpage>
                  <pub-id pub-id-type="pmid">21731036</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib13">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Kannan</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>McVie</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Bocchini</surname>
                      <given-names>JA</given-names>
                    </name>
                  </person-group>
                  <article-title>Hyperketonemia increases TNF-α secretion in cultured U937 monocytes and type-1 diabetic patients and is apparently mediated by oxidative stress and cAMP-deficiency</article-title>
                  <source>Diabetes</source>
                  <year>2002</year>
                  <volume>51</volume>
                  <fpage>2287</fpage>
                  <lpage>2293</lpage>
                  <pub-id pub-id-type="pmid">12086962</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib14">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pfeiffer</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Huff</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Gunter</surname>
                      <given-names>EW</given-names>
                    </name>
                  </person-group>
                  <article-title>Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting</article-title>
                  <source>Clin Chem</source>
                  <year>1999</year>
                  <volume>45</volume>
                  <fpage>290</fpage>
                  <lpage>292</lpage>
                  <pub-id pub-id-type="pmid">9931056</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib15">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Kahlon</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Morehead</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Lieblong</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Stapleton</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Hoeldtke</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The effect of sleep apnea and insomnia on blood levels of leptin, insulin resistance, IP-10, and hydrogen sulfide in type 2 diabetic patients</article-title>
                  <source>Metab Syndr Relat Disord</source>
                  <year>2012</year>
                  <volume>10</volume>
                  <fpage>331</fpage>
                  <lpage>336</lpage>
                  <pub-id pub-id-type="pmid">22746298</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib16">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sokol</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Heubi</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Iannaccone</surname>
                      <given-names>ST</given-names>
                    </name>
                    <name>
                      <surname>Bove</surname>
                      <given-names>KE</given-names>
                    </name>
                    <name>
                      <surname>Balistreri</surname>
                      <given-names>WF</given-names>
                    </name>
                  </person-group>
                  <article-title>Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis</article-title>
                  <source>N Engl J Med</source>
                  <year>1984</year>
                  <volume>310</volume>
                  <fpage>1209</fpage>
                  <lpage>1212</lpage>
                  <pub-id pub-id-type="pmid">6709026</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib17">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Franklin</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Backos</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Mohar</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Forman</surname>
                      <given-names>HJ</given-names>
                    </name>
                    <name>
                      <surname>Kavanagh</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase</article-title>
                  <source>Mol Aspects of Med</source>
                  <year>2009</year>
                  <volume>30</volume>
                  <fpage>86</fpage>
                  <lpage>98</lpage>
                  <pub-id pub-id-type="pmid">18812186</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib18">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Micinski</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U-937 monocytes</article-title>
                  <source>Biochem Biophys Res Commun</source>
                  <year>2013</year>
                  <volume>437</volume>
                  <fpage>7</fpage>
                  <lpage>11</lpage>
                  <pub-id pub-id-type="pmid">23770363</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib19">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                  </person-group>
                  <article-title>Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells</article-title>
                  <source>J Biol Chem</source>
                  <year>1989</year>
                  <volume>264</volume>
                  <fpage>21340</fpage>
                  <lpage>21345</lpage>
                  <pub-id pub-id-type="pmid">2592379</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib20">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>McVie</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Duett</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Herbst</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes</article-title>
                  <source>Diabetes</source>
                  <year>1989</year>
                  <volume>38</volume>
                  <fpage>1539</fpage>
                  <lpage>1543</lpage>
                  <pub-id pub-id-type="pmid">2583378</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib21">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rains</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                  </person-group>
                  <article-title>Oxidative stress, insulin signaling, and diabetes</article-title>
                  <source>Free Radic Biol Med</source>
                  <year>2011</year>
                  <volume>50</volume>
                  <fpage>567</fpage>
                  <lpage>575</lpage>
                  <pub-id pub-id-type="pmid">21163346</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib22">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Krause</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Rodrigues-Krause</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>O'Hagan</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>De Vito</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Boreham</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Susta</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Differential nitric oxide levels in the blood and skeletal muscle of type 2 diabetic subjects may be consequence of adiposity: a preliminary study</article-title>
                  <source>Metabolism</source>
                  <year>2012</year>
                  <volume>61</volume>
                  <fpage>1528</fpage>
                  <lpage>1537</lpage>
                  <pub-id pub-id-type="pmid">22683098</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib23">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ji</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Jiang</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Sheng</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanism</article-title>
                  <source>J Nutr Biochem</source>
                  <year>2013</year>
                  <volume>24</volume>
                  <fpage>1911</fpage>
                  <lpage>1919</lpage>
                  <pub-id pub-id-type="pmid">24011717</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib24">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Velusamy</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Croad</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Rains</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Bull</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, oxidative stress and inhibits NFkB activation in the livers of Zucker diabetic rats</article-title>
                  <source>Free Radic Biol Med</source>
                  <year>2009</year>
                  <volume>46</volume>
                  <fpage>1633</fpage>
                  <lpage>1638</lpage>
                  <pub-id pub-id-type="pmid">19328229</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib25">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aune</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Norat</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Romundstad</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Vatten</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies</article-title>
                  <source>Am J Clin Nutr</source>
                  <year>2013</year>
                  <volume>98</volume>
                  <fpage>1066</fpage>
                  <lpage>1083</lpage>
                  <pub-id pub-id-type="pmid">23945722</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib26">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Diniz</surname>
                      <given-names>YS</given-names>
                    </name>
                    <name>
                      <surname>Rocha</surname>
                      <given-names>KK</given-names>
                    </name>
                    <name>
                      <surname>Souza</surname>
                      <given-names>GA</given-names>
                    </name>
                    <name>
                      <surname>Galhardi</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Ebaid</surname>
                      <given-names>GM</given-names>
                    </name>
                    <name>
                      <surname>Rodrigues</surname>
                      <given-names>HG</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats</article-title>
                  <source>Eur J Pharmacol</source>
                  <year>2006</year>
                  <volume>543</volume>
                  <fpage>151</fpage>
                  <lpage>157</lpage>
                  <pub-id pub-id-type="pmid">16814277</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib27">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gaudel</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Nongonierma</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>Maher</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Flynn</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Krause</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>BA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice</article-title>
                  <source>J Nutr</source>
                  <year>2013</year>
                  <volume>143</volume>
                  <fpage>1109</fpage>
                  <lpage>1114</lpage>
                  <pub-id pub-id-type="pmid">23658425</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib28">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shertzer</surname>
                      <given-names>HG</given-names>
                    </name>
                    <name>
                      <surname>Woods</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Krishan</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Genter</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Pearson</surname>
                      <given-names>KJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet</article-title>
                  <source>J Nutr</source>
                  <year>2011</year>
                  <volume>141</volume>
                  <fpage>582</fpage>
                  <lpage>587</lpage>
                  <pub-id pub-id-type="pmid">21310864</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib29">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Zeng</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats</article-title>
                  <source>Chem Biol Interact</source>
                  <year>2008</year>
                  <volume>173</volume>
                  <fpage>68</fpage>
                  <lpage>75</lpage>
                  <pub-id pub-id-type="pmid">18377884</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib30">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pieper</surname>
                      <given-names>GM</given-names>
                    </name>
                    <name>
                      <surname>Siebeneich</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction</article-title>
                  <source>J Cardiovasc Pharmacol</source>
                  <year>1998</year>
                  <volume>32</volume>
                  <fpage>101</fpage>
                  <lpage>105</lpage>
                  <pub-id pub-id-type="pmid">9676728</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib31">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Martina</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Masha</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gigliardi</surname>
                      <given-names>VR</given-names>
                    </name>
                    <name>
                      <surname>Brocato</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Manzato</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Berchio</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes</article-title>
                  <source>Diab Care</source>
                  <year>2008</year>
                  <volume>31</volume>
                  <fpage>940</fpage>
                  <lpage>944</lpage>
                </mixed-citation>
              </ref>
              <ref id="bib32">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ozkilic</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Cengiz</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ozaydin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cobanoglu</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kanigur</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>The role of N-acetylcysteine treatment on anti-oxidative status in patients with type II diabetes mellitus</article-title>
                  <source>J Basic Clin Physiol Pharmacol</source>
                  <year>2006</year>
                  <volume>17</volume>
                  <fpage>245</fpage>
                  <lpage>254</lpage>
                  <pub-id pub-id-type="pmid">17338280</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib33">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Neri</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Signorelli</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Torrisi</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Pulvirenti</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Mauceri</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Abate</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls</article-title>
                  <source>Clin Ther</source>
                  <year>2005</year>
                  <volume>27</volume>
                  <fpage>1764</fpage>
                  <lpage>1773</lpage>
                  <pub-id pub-id-type="pmid">16368447</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib34">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gunnerud</surname>
                      <given-names>UJ</given-names>
                    </name>
                    <name>
                      <surname>Ostman</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Björck</surname>
                      <given-names>IM</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of whey proteins on glycaemia and insulinaemia to an oral glucose load in healthy adults; a dose-response study</article-title>
                  <source>Eur J Clin Nutr</source>
                  <year>2013</year>
                  <volume>67</volume>
                  <fpage>749</fpage>
                  <lpage>753</lpage>
                  <pub-id pub-id-type="pmid">23632747</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib35">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mortensen</surname>
                      <given-names>LS</given-names>
                    </name>
                    <name>
                      <surname>Holmer-Jensen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hartvigsen</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Jensen</surname>
                      <given-names>VK</given-names>
                    </name>
                    <name>
                      <surname>Astrup</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>de Vrese</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effects of different fractions of whey protein on postprandial lipid and hormone responses in type 2 diabetes</article-title>
                  <source>Eur J Clin Nutr</source>
                  <year>2012</year>
                  <volume>66</volume>
                  <fpage>799</fpage>
                  <lpage>805</lpage>
                  <pub-id pub-id-type="pmid">22588635</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib36">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ried</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Frank</surname>
                      <given-names>OR</given-names>
                    </name>
                    <name>
                      <surname>Stocks</surname>
                      <given-names>NP</given-names>
                    </name>
                  </person-group>
                  <article-title>Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial</article-title>
                  <source>Eur J Clin Nutr</source>
                  <year>2013</year>
                  <volume>67</volume>
                  <fpage>64</fpage>
                  <lpage>70</lpage>
                  <pub-id pub-id-type="pmid">23169470</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib37">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Kahlon</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Morehead</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Dhawan</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Lieblong</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Stapleton</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-α, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study</article-title>
                  <source>Mol Nutr Food Res</source>
                  <year>2012</year>
                  <volume>56</volume>
                  <fpage>1333</fpage>
                  <lpage>1341</lpage>
                  <pub-id pub-id-type="pmid">22674882</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib38">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>De Mattia</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Bravi</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Laurenti</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Cassone-Faldetta</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Armiento</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ferri</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus</article-title>
                  <source>Metabolism</source>
                  <year>1998</year>
                  <volume>47</volume>
                  <fpage>993</fpage>
                  <lpage>997</lpage>
                  <pub-id pub-id-type="pmid">9711998</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib39">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>BS</given-names>
                    </name>
                    <name>
                      <surname>Cha</surname>
                      <given-names>HN</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>YW</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>JY</given-names>
                    </name>
                    <name>
                      <surname>Dan</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>SY</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Inhibition of lipid infusion-induced skeletal muscle insulin resistance by cotreatment with tempol and glutathione in mice</article-title>
                  <source>J Pharmacol Sci</source>
                  <year>2009</year>
                  <volume>110</volume>
                  <fpage>370</fpage>
                  <lpage>380</lpage>
                  <pub-id pub-id-type="pmid">19609068</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib40">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Guarino</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Macedo</surname>
                      <given-names>MP</given-names>
                    </name>
                  </person-group>
                  <article-title>Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats</article-title>
                  <source>Br J Pharmacol</source>
                  <year>2006</year>
                  <volume>147</volume>
                  <fpage>959</fpage>
                  <lpage>965</lpage>
                  <pub-id pub-id-type="pmid">16491098</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib41">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nguyen</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Hsu</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Jahoor</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Sekhar</surname>
                      <given-names>RV</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity and body composition in older HIV-infected patients</article-title>
                  <source>J Clin Endocrinol Metab</source>
                  <year>2014</year>
                  <volume>99</volume>
                  <fpage>169</fpage>
                  <lpage>177</lpage>
                  <pub-id pub-id-type="pmid">24081740</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib42">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Borges</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Martini</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Rogero</surname>
                      <given-names>MM</given-names>
                    </name>
                  </person-group>
                  <article-title>Current prospective on vitamin D, immune system, and chronic diseases</article-title>
                  <source>Nutrition</source>
                  <year>2011</year>
                  <volume>27</volume>
                  <fpage>399</fpage>
                  <lpage>404</lpage>
                  <pub-id pub-id-type="pmid">20971616</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib43">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Manna</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                  </person-group>
                  <article-title>Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-γ-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes</article-title>
                  <source>J Biol Chem</source>
                  <year>2012</year>
                  <volume>287</volume>
                  <fpage>42324</fpage>
                  <lpage>42332</lpage>
                  <pub-id pub-id-type="pmid">23074218</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib44">
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jain</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Manna</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Micinski</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Lieblong</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Kahlon</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Morehead</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>In African American type 2 diabetic patients, is vitamin D deficiency associated with lower blood levels of hydrogen sulfide and cyclic adenosine monophosphate, and elevated oxidative stress</article-title>
                  <source>Antioxid Redox Signal</source>
                  <year>2013</year>
                  <volume>18</volume>
                  <fpage>1154</fpage>
                  <lpage>1158</lpage>
                  <pub-id pub-id-type="pmid">22852873</pub-id>
                </mixed-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="fig1">
              <label>Figure 1</label>
              <caption>
                <p>The regression analyses between plasma levels of GSH and L-cysteine (<bold>d</bold>), GSH and vitamin D expressed per lipid (n<sc>M</sc>/μ<sc>M</sc> triglycerides and cholesterol) (<bold>a</bold>), GSH and vitamin D expressed per n<sc>M</sc> (<bold>b</bold>) and L-cysteine and vitamin D (<bold>c</bold>) in the plasma of type 2 diabetic patients. Note the significant relationship between GSH and L-cysteine when vitamin D is expressed per lipid or per ml plasma.</p>
              </caption>
              <graphic xlink:href="ejcn2014114f1"/>
            </fig>
            <fig id="fig2">
              <label>Figure 2</label>
              <caption>
                <p>The regression analyses between levels of GSH (<bold>f</bold>) and L-cysteine (<bold>c</bold>) and triglycerides, and vitamin D (<bold>e</bold>) and triglyceride (<bold>b</bold>) and insulin resistance levels in the plasma of type 2 diabetic patients. Note the significant negative relationship between GSH and L-cysteine levels and those of triglycerides; and of HbA<sub>1c</sub> with that of vitamin D expressed per n<sc>M</sc> plasma (<bold>a</bold>) or with vitamin D expressed per lipid (n<sc>M</sc>/μ<sc>M</sc> triglycerides and cholesterol (<bold>d</bold>)) in the plasma of type 2 diabetic patients. Note a significant negative relationship between vitamin D and HOMA IR, and a positive relationship between levels of triglyceride and HOMA IR; and of HbA<sub>1c</sub> with that of vitamin D status in the blood of type 2 diabetic patients.</p>
              </caption>
              <graphic xlink:href="ejcn2014114f2"/>
            </fig>
            <fig id="fig3">
              <label>Figure 3</label>
              <caption>
                <p>Effect of L-cysteine (left panel) and vitamin D (right panel) supplementation on upregulation of glutamate–cysteine ligase (GCLC) and GSH levels in U937 monocytes cultured with high glucose. Values are mean±s.e. (<italic>n</italic>=3).</p>
              </caption>
              <graphic xlink:href="ejcn2014114f3"/>
            </fig>
            <table-wrap id="tbl1">
              <label>Table 1</label>
              <caption>
                <title>Age, BMI, F/M ratio, fasting glucose levels and insulin resistance, triglyceride, vitamin D, <sc>L</sc>-cysteine, GSH and GCLC levels in type 2 diabetic patients and controls</title>
              </caption>
              <table frame="hsides" rules="groups" border="1">
                <colgroup>
                  <col align="left"/>
                  <col align="center"/>
                  <col align="center"/>
                </colgroup>
                <thead valign="bottom">
                  <tr>
                    <th align="left" valign="top" charoff="50"> </th>
                    <th align="center" valign="top" charoff="50">
                      <italic>Type 2 diabetics</italic>
                    </th>
                    <th align="center" valign="top" charoff="50">
                      <italic>Controls</italic>
                    </th>
                  </tr>
                </thead>
                <tbody valign="top">
                  <tr>
                    <td align="left" valign="top" charoff="50">
                      <italic>n</italic>
                    </td>
                    <td align="center" valign="top" charoff="50">79</td>
                    <td align="center" valign="top" charoff="50">22</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">Age (years)</td>
                    <td align="char" valign="top" char="±" charoff="50">49.6±1.03</td>
                    <td align="char" valign="top" char="±" charoff="50">47.6±1.9</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">M/F</td>
                    <td align="center" valign="top" charoff="50">59/20</td>
                    <td align="center" valign="top" charoff="50">16/6</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">African Americans/Caucasians</td>
                    <td align="center" valign="top" charoff="50">54/25</td>
                    <td align="center" valign="top" charoff="50">14/8</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">Body weight (kg)</td>
                    <td align="char" valign="top" char="±" charoff="50">102.9±3.4</td>
                    <td align="char" valign="top" char="±" charoff="50">85.1±4.4<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">BMI</td>
                    <td align="char" valign="top" char="±" charoff="50">36.6±1.02</td>
                    <td align="char" valign="top" char="±" charoff="50">29.8±1.3<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">Blood glucose (mg%)</td>
                    <td align="char" valign="top" char="±" charoff="50">138.8±6.1</td>
                    <td align="char" valign="top" char="±" charoff="50">93.2±3.9<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">HbA<sub>1C</sub> (%)</td>
                    <td align="char" valign="top" char="±" charoff="50">7.8±0.2</td>
                    <td align="center" valign="top" charoff="50">ND</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">HOMA IR</td>
                    <td align="char" valign="top" char="±" charoff="50">5.42±0.5</td>
                    <td align="char" valign="top" char="±" charoff="50">2.74±0.24<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">TG (mg%)</td>
                    <td align="char" valign="top" char="±" charoff="50">171.2±15.4</td>
                    <td align="char" valign="top" char="±" charoff="50">105.9±12.2<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">Vitamin D (nmol/l)</td>
                    <td align="char" valign="top" char="±" charoff="50">15.9±0.96</td>
                    <td align="char" valign="top" char="±" charoff="50">20.8±1.8<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">Vitamin D (n<sc>M</sc>/μ<sc>M</sc> TG+chol)</td>
                    <td align="char" valign="top" char="±" charoff="50">2.6±0.17</td>
                    <td align="char" valign="top" char="±" charoff="50">3.2±0.34<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">L-cysteine (μ<sc>M</sc>)</td>
                    <td align="char" valign="top" char="±" charoff="50">288.2±11.9</td>
                    <td align="char" valign="top" char="±" charoff="50">357.6±16.7<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">GSH (μ<sc>M</sc>)</td>
                    <td align="char" valign="top" char="±" charoff="50">65.4±2.8</td>
                    <td align="char" valign="top" char="±" charoff="50">89.4±5.2<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" charoff="50">GCLC (ng/ml)</td>
                    <td align="char" valign="top" char="±" charoff="50">0.23±0.03</td>
                    <td align="char" valign="top" char="±" charoff="50">0.43±0.08<xref ref-type="fn" rid="t1-fn3">a</xref></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="t1-fn1">
                  <p>Abbreviations: BMI, body mass index; chol, cholesterol; F, female; GCLC, glycine–cysteine ligase catalytic unit; GSH, glutathione; HOMA IR, homeostatic model assessment insulin resistance; M, male; ND, not determined; TG, triglycerides.</p>
                </fn>
                <fn id="t1-fn2">
                  <p>Controls are nondiabetic healthy subjects. HOMA IR was calculated using the formula: (plasma insulin (μU/ml) × glucose (mg%))/405. Values are mean±s.e.</p>
                </fn>
                <fn id="t1-fn3">
                  <label>a</label>
                  <p>Values marked were significantly different (<italic>P</italic>&lt;0.05) between the groups.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
